CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 551,287	$ 1,040,039
Restricted cash and equivalents	[1]	13,192	14,781
Marketable securities		407,993
Receivables, net		637,731	293,407
Prepaid expenses and other current assets, net		24,067	18,968
Total current assets		1,634,270	1,367,195
Property and equipment, net		17,940	9,161
Intangible assets, net		60,602	55,398
Goodwill		41,540	41,540
Other assets, net		116,083	112,958
Total assets		1,870,435	1,586,252
Current liabilities:
Medical claims and related payables		490,840	239,014
Accounts payable and accrued expenses		162,386	112,946
Current portion of long-term debt		5,000	5,000
Total current liabilities		658,226	356,960
Long-term debt, net of current portion		39,713	43,401
Other liabilities		87,207	94,295
Total liabilities		785,146	494,656
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 408,204 and 400,095 shares issued and outstanding, respectively		4,117	4,001
Additional paid-in capital		2,094,562	2,045,572
Accumulated deficit		(1,007,764)	(957,677)
Accumulated other comprehensive income (loss)		(5,098)	0
Total agilon health, inc. stockholders' equity (deficit)		1,085,817	1,091,896
Noncontrolling interests		(528)	(300)
Total stockholders’ equity (deficit)		1,085,289	1,091,596
Total liabilities and stockholders' equity (deficit)		$ 1,870,435	$ 1,586,252

[1] Restricted cash and equivalents primarily consist of amounts used as collateral to secure letters of credit that the Company is required to maintain pursuant to contracts with payors.